Smart Syringe Market, by Product Type (Auto-disable Syringes, Active Safety Syringes, and Passive Safety Syringes), by Application (Vaccination, Drug Delivery, and Blood Specimen Collection), by End User (Hospitals & Clinics, Diagnostic Laboratories, and Homecare Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Sep 2023

Code : CMI4394

Pages :210

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Smart Syringe Market: Key Developments

On March 17, 2023, Stevanato Group, a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical industry, announced a partnership with Recipharm AB, a pharmaceutical contract development and manufacturing organization, to provide pre-fillable syringes for Recipharm’s new soft mist inhaler. Under the partnership, Stevanato Group will develop and manufacture its glass pre-fillable syringe Alba, integrated with Recipharm’s soft mist inhaler technology.
On February 20, 2023, Zephyrus Innovations (Zephyrus), a privately-owned medical device company designing and manufacturing safety syringes, announced that it had received its first product 510(k) marketing approval from the US Food and Drug Administration (FDA) for its Aeroject 3 ml safety syringe. Zephyrus’ syringes are for general medical use in healthcare facilities by medical professionals for pediatric and adult patients for aspiration and injection of fluids.
In September 2022, Becton, Dickinson and Company, a leading medical technology company, introduced a next-generation glass prefillable syringe (PFS) that sets a new standard in performance for vaccine PFS with new and tightened specifications for processability, cosmetics, contamination, and integrity.
In January 2022, Dali Medical Devices, a medical device company, announced that it completed the first commercial implementation of the SAN-Light passive safety needle.